Factor IX a inhibition contributes to the heparin effect

Area of Science:

• Biochemistry
• Pharmacology

Background:

• Heparin is a widely used anticoagulant.
• Its precise mechanism in inhibiting thrombin formation in the intrinsic pathway is not fully elucidated.
• Understanding heparin's action is crucial for optimizing anticoagulant therapy.

Purpose of the Study:

• To investigate the role of factor IXa inactivation in heparin's anticoagulant effect.
• To compare heparin's action with a combination of dermatan sulfate and a synthetic pentasaccharide.
• To determine if heparin has an inhibitory effect beyond its known mechanisms.

Main Methods:

• Compared unfractionated heparin (0.05 U/ml) with a mixture of dermatan sulfate (DS) and a synthetic pentasaccharide (PS).
• DS was used to enhance heparin cofactor II activity (thrombin inhibition).
• PS was used to enhance antithrombin III (AT III) activity against factor Xa.

Main Results:

• Heparin demonstrated an additional inhibitory effect compared to the DS/PS mixture.
• This extra inhibition was observed when free factor IXa limited thrombin formation.
• Contact activated plasma showed this enhanced heparin effect.

Conclusions:

• Heparin's inactivation of free factor IXa is a significant contributor to thrombin formation inhibition.
• This mechanism is important in the intrinsic coagulation system.
• Heparin's action is crucial in tests like the activated partial thromboplastin time.